4//SEC Filing
van Hylckama Vlieg Johan 4
Accession 0001209191-22-003534
CIK 0001751299other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 5:18 PM ET
Size
5.6 KB
Accession
0001209191-22-003534
Insider Transaction Report
Form 4
van Hylckama Vlieg Johan
Chief Scientific Officer
Transactions
- Award
Restricted Stock Units
2022-01-14+350,000→ 350,000 total→ Common Stock (350,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
- [F2]The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.
Documents
Issuer
Kaleido Biosciences, Inc.
CIK 0001751299
Entity typeother
Related Parties
1- filerCIK 0001861087
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 5:18 PM ET
- Size
- 5.6 KB